|
1
|
GBD 2019 Diseases and Injuries
Collaborators. Global burden of 369 diseases and injuries in 204
countries and territories, 1990-2019: A systematic analysis for the
global burden of disease study 2019. Lancet. 396:1204–1222.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Souza JA, Rossa C Jr, Garlet GP, Nogueira
AV and Cirelli JA: Modulation of host cell signaling pathways as a
therapeutic approach in periodontal disease. J Appl Oral Sci.
20:128–138. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Giannobile WV: Host-response therapeutics
for periodontal diseases. J Periodontol. 79 (8 Suppl):S1592–S1600.
2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Califf RM: Biomarker definitions and their
applications. Exp Biol Med (Maywood). 243:213–221. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Georgiou AC, Crielaard W, Armenis I, de
Vries R and van der Waal SV: Apical periodontitis is associated
with elevated concentrations of inflammatory mediators in
peripheral blood: A systematic review and meta-analysis. J Endod.
45:1279–1295.e3. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Moreno-Expósito L, Illescas-Montes R,
Melguizo-Rodríguez L, Ruiz C, Ramos-Torrecillas J and de
Luna-Bertos E: Multifunctional capacity and therapeutic potential
of lactoferrin. Life Sci. 195:61–64. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
El-Fakharany EM, Ashry M, Abd-Elaleem AH,
Romeih MH, Morsy FA, Shaban RA and Abdel-Wahhab KG: Therapeutic
efficacy of Nano-formulation of lactoperoxidase and lactoferrin via
promoting immunomodulatory and apoptotic effects. Int J Biol
Macromo. 220:43–55. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
El Amrousy D, El-Afify D, Elsawy A,
Elsheikh M, Donia A and Nassar M: Lactoferrin for iron-deficiency
anemia in children with inflammatory bowel disease: A clinical
trial. Pediatr Res. 92:762–766. 2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Glimvall P, Wickström C and Jansson H:
Elevated levels of salivary lactoferrin, a marker for chronic
periodontitis? J Periodontal Res. 47:655–660. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kivadasannavar AV, Pudakalakatti PS,
Hattarki SA and Kambali SS: Estimation of lactoferrin levels in
gingival crevicular fluid before and after periodontal therapy in
patients with chronic periodontitis. Contemp Clin Dent. 5:25–30.
2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ramenzoni LL, Hofer D, Solderer A,
Wiedemeier D, Attin T and Schmidlin PR: Origin of MMP-8 and
lactoferrin levels from gingival crevicular fluid, salivary glands
and whole saliva. BMC Oral Health. 21(385)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Orhue VE, Ehizele AO, Akhionbare O and
Ojehanon P: Salivary lactoferrin levels, disease severity and
correlates in patients with chronic periodontitis presenting to a
tertiary health facility in Nigeria. Nig J Dent Res. 7:60–66.
2022.
|
|
13
|
Hu P, Zhao F, Wang J and Zhu W:
Lactoferrin attenuates lipopolysaccharide-stimulated inflammatory
responses and barrier impairment through the modulation of
NF-κB/MAPK/Nrf2 pathways in IPEC-J2 cells. Food Funct.
11:8516–8526. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Trybek G, Jedliński M, Jaroń A, Preuss O,
Mazur M and Grzywacz A: Impact of lactoferrin on bone regenerative
processes and its possible implementation in oral surgery-a
systematic review of novel studies with metanalysis and
metaregression. BMC Oral Health. 20(232)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Vrabel M: Preferred reporting items for
systematic reviews and meta-analyses. Oncol Nurs Forum. 42:552–554.
2015.
|
|
16
|
Aydin S, Emre E, Ugur K, Aydin MA, Sahin
İ, Cinar V and Akbulut T: An overview of ELISA: A review and update
on best laboratory practices for quantifying peptides and proteins
in biological fluids. J Int Med Res.
53(3000605251315913)2025.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wells G, Shea B, O'Connell D, Robertson J,
Peterson J, Welch V, Losos M and Tugwell P: The Newcastle-Ottawa
Scale (NOS) for assessing the quality of nonrandomised studies in
meta-analyses. In 3rd Symposium on Systematic Reviews: Beyond the
Basics, Oxford, UK, pp2000, 2014.
|
|
18
|
Jadad AR, Moore RA, Carroll D, Jenkinson
C, Reynolds DJ, Gavaghan DJ and McQuay HJ: Assessing the quality of
reports of randomized clinical trials: Is blinding necessary?
Control Clin Trials. 17:1–12. 1996.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Slim K, Nini E, Forestier D, Kwiatkowski
F, Panis Y and Chipponi J: Methodological index for non-randomized
studies (minors): Development and validation of a new instrument.
ANZ J Surg. 73:712–716. 2003.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wetterslev J, Thorlund K, Brok J and Gluud
C: Estimating required information size by quantifying diversity in
random-effects model meta-analyses. BMC Med Res Methodol.
9(86)2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Andrade C: Mean difference, standardized
mean difference (SMD), and their use in meta-analysis: As simple as
it gets. J Clin Psychiatry. 81(20f13681)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Huedo-Medina TB, Sánchez-Meca J,
Marín-Martínez F and Botella J: Assessing heterogeneity in
meta-analysis: Q statistic or I2 index? Psychol Methods.
11:193–206. 2006.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lin L and Chu H: Quantifying publication
bias in meta-analysis. Biometrics. 74:785–794. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Vozna IV, Pavlov SV and Voznyi OV: The
influence of oral antimicrobial peptide content on the quantitative
microflora composition in periodontal pockets among residents of a
large industrial region. Zaporozhye Med J. 23:388–394. 2021.
|
|
25
|
Talib HJ and Ahmed MA: Assessment of
salivary lactoferrin and pH levels and their correlation with
gingivitis and severity of chronic periodontitis (part: 2). J Bagh
Coll Dent. 30:46–52. 2018.
|
|
26
|
Yadav N, Lamba AK, Thakur A, Faraz F,
Tandon S and Pahwa P: Effect of periodontal therapy on lactoferrin
levels in gingival crevicular fluid. Aust Dent J. 59:314–320.
2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Figueredo CM, Ribeiro MS, Fischer RG and
Gustafsson A: Increased interleukin-1beta concentration in gingival
crevicular fluid as a characteristic of periodontitis. J
Periodontol. 70:1457–1463. 1999.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tsai CC, Kao CC and Chen CC: Gingival
crevicular fluid lactoferrin levels in adult periodontitis
patients. Aust Dent J. 43:40–44. 1998.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Adonogianaki E, Moughal NA and Kinane DF:
Lactoferrin in the gingival crevice as a marker of
polymorphonuclear leucocytes in periodontal diseases. J Clin
Periodontol. 20:26–31. 1993.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Mandra EV, Sementsova EA, Polushina LG,
Svetlakova EN, Mandra JV and Bazarnyj VV: Comparance specifics of
lactoferrin in saliva secretion of patients with viral and
bacterial diseases in oral cavity. Materials of the International
Congress ''Dentistry of the Great Urals''. December. 4-6:2019.
|
|
31
|
Wu Y, Shu R, Luo LJ, Ge LH and Xie YF:
Initial comparison of proteomic profiles of whole unstimulated
saliva obtained from generalized aggressive periodontitis patients
and healthy control subjects. J Periodontal Res. 44:636–644.
2009.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Murray MC, Mooney J and Kinane DF: The
relationship between elastase and lactoferrin in healthy,
gingivitis and periodontitis sites. Oral Dis. 1:106–109.
1995.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Shimizu E, Kobayashi T, Wakabayashi H,
Yamauchi K, Iwatsuki K and Yoshie H: Effects of orally administered
lactoferrin and lactoperoxidase-containing tablets on clinical and
bacteriological profiles in chronic periodontitis patients. Int J
Dent. 2011(405139)2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wei PF, Ho KY, Ho YP, Wu YM, Yang YH and
Tsai CC: The investigation of glutathione peroxidase, lactoferrin,
myeloperoxidase and interleukin-1beta in gingival crevicular fluid:
Implications for oxidative stress in human periodontal diseases. J
Periodontal Res. 39:287–293. 2004.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Figueredo CM and Gustafsson A: Increased
amounts of laminin in GCF from untreated patients with
periodontitis. J Clin Periodontol. 27:313–318. 2000.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Legrand D, Elass E, Carpentier M and
Mazurier J: Lactoferrin: A modulator of immune and inflammatory
responses. Cell Mol Life Sci. 62:2549–2559. 2005.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Actor JK, Hwang SA and Kruzel ML:
Lactoferrin as a natural immune modulator. Curr Pharm Des.
15:1956–1973. 2009.PubMed/NCBI View Article : Google Scholar : Qin X, Li D, Qin
X, Chen F, Guo H, Gui Y, Zhao J, Jiang L and Luo D: Electrochemical
detection of the cardiac biomarker cardiac troponin I. View 5:
20240025, 2024.
|
|
38
|
Xu M, Lin C, Zhao S, Zhang W, Li D, Fang
F, Teng Z, Peng Y, Liu M, Huang Z, et al: A versatile catalytic and
photothermal lateral flow immunoassay based on ultrathin
Fe-MoS2 nanosheets for sensitive and accurate detection
of influenza A. View. 5(20240067)2024.
|
|
39
|
Wu J, Wei Y, Shi C, Huang Y, Hong Z, Liu
W, Gu L, Wang R, Li Y, Cao J, et al: Thermally engineered ferric
yolk-shells for vaginal secretion-based cervical cancer screening.
Adv Funct Mater. 34(2312380)2024.
|
|
40
|
Su H, Zhang H, Wu J, Huang L, Zhang M, Xu
W, Cao J, Liu W, Liu N, Jiang H, et al: Fast label-free metabolic
profile recognition identifies phenylketonuria and subtypes. Adv
Sci (Weinh). 11(e2305701)2024.PubMed/NCBI View Article : Google Scholar
|
